Agilent Technologies (A) Updates Q3 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its third quarter earnings guidance on Tuesday morning. The company provided earnings per share guidance of $0.71-0.73 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.73. The company issued revenue guidance of $1.23-1.25 billion, compared to the consensus revenue estimate of $1.27 billion.Agilent Technologies also updated its FY 2019 guidance to $3.03-3.07 EPS.

A has been the topic of several recent research reports. Deutsche Bank reiterated a buy rating and set a $90.00 price objective on shares of Agilent Technologies in a research report on Thursday, February 21st. Cowen lifted their target price on Agilent Technologies from $80.00 to $90.00 and gave the company an outperform rating in a research report on Tuesday, March 26th. Robert W. Baird restated a buy rating and issued a $82.00 target price (up from $77.00) on shares of Agilent Technologies in a research note on Wednesday, February 20th. Zacks Investment Research cut Agilent Technologies from a buy rating to a hold rating in a report on Wednesday, January 23rd. Finally, Barclays increased their target price on Agilent Technologies from $80.00 to $83.00 and gave the stock an overweight rating in a research report on Thursday, February 21st. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Agilent Technologies has an average rating of Buy and an average price target of $87.17.

Agilent Technologies stock traded up $2.17 during mid-day trading on Tuesday, reaching $76.01. The stock had a trading volume of 2,273,568 shares, compared to its average volume of 1,895,391. The stock has a market capitalization of $24.48 billion, a PE ratio of 27.24, a price-to-earnings-growth ratio of 2.14 and a beta of 1.33. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.79 and a current ratio of 3.39. Agilent Technologies has a fifty-two week low of $60.42 and a fifty-two week high of $82.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Tuesday, May 14th. The medical research company reported $0.71 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.01). The firm had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.27 billion. Agilent Technologies had a return on equity of 19.90% and a net margin of 22.86%. Agilent Technologies’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.65 earnings per share. Research analysts forecast that Agilent Technologies will post 3.06 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 24th. Investors of record on Tuesday, April 2nd were given a dividend of $0.164 per share. The ex-dividend date was Monday, April 1st. This represents a $0.66 annualized dividend and a dividend yield of 0.86%. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.66%.

In other news, VP Mark Doak sold 16,421 shares of the stock in a transaction on Friday, February 22nd. The shares were sold at an average price of $77.95, for a total value of $1,280,016.95. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Michael R. Mcmullen sold 8,746 shares of the stock in a transaction on Friday, February 15th. The shares were sold at an average price of $77.67, for a total transaction of $679,301.82. Following the transaction, the chief executive officer now owns 447,684 shares in the company, valued at $34,771,616.28. The disclosure for this sale can be found here. Insiders have sold a total of 57,329 shares of company stock valued at $4,535,225 in the last ninety days.

TRADEMARK VIOLATION NOTICE: This news story was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: Systematic Risk and Investors

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with's FREE daily email newsletter.

Leave a Reply